Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Murray

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Neurology|March 28, 2020
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive declineJoanne Ryan, Elsdon Storey, Anne M Murray, et al.
Neurology|January 29, 2025
Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older AdultsZhen Zhou, Chris Moran, Anne M Murray, et al.
Alzheimer'S Research & Therapy|May 18, 2024
The impact of incident stroke on cognitive trajectories in later lifeSwarna Vishwanath, Ingrid Hopper, Geoffrey C Cloud, et al.
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Age and Ageing|September 18, 2025
The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adultsCatherine Robb, Amy Brodtmann, Robyn L Woods, et al.
JAMA Cardiology|October 15, 2025
Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of AspirinZoe K McQuilten, Le T P Thao, Alexander G Bick, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
The Lancet. Neurology|October 1, 2011
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudyLenore J Launer, Michael E Miller, Jeff D Williamson, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Neurology|March 28, 2020
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive declineJoanne Ryan, Elsdon Storey, Anne M Murray, et al.
Neurology|January 29, 2025
Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older AdultsZhen Zhou, Chris Moran, Anne M Murray, et al.
Alzheimer'S Research & Therapy|May 18, 2024
The impact of incident stroke on cognitive trajectories in later lifeSwarna Vishwanath, Ingrid Hopper, Geoffrey C Cloud, et al.
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Age and Ageing|September 18, 2025
The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adultsCatherine Robb, Amy Brodtmann, Robyn L Woods, et al.
JAMA Cardiology|October 15, 2025
Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of AspirinZoe K McQuilten, Le T P Thao, Alexander G Bick, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
The Lancet. Neurology|October 1, 2011
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudyLenore J Launer, Michael E Miller, Jeff D Williamson, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Pageof 15